SCHEMBL6896916

SCHEMBL6896916

COc1cc(C)c(C)cc1NC(=NO)N1CCN(c2cc(F)cc(F)c2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
LMNA P02545 3/20 0.40
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAOB P27338 1/20 0.38
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
POLB P06746 2/20 0.36
RBP4 P02753 1/20 0.36
TSHR P16473 2/20 0.36
HTR1A P08908 1/20 0.35
HTR1D P28221 1/20 0.35
HTR1B P28222 1/20 0.35
HTR2A P28223 1/20 0.35
USP2 O75604 1/20 0.34
TP53 P04637 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6898814 0.88 CYP3A4 (0.42) ALDH1A1LMNAMAPTNPSR1CYP3A4
SCHEMBL6898372 0.87 CYP3A4 (0.47) ALDH1A1LMNAMAPTCYP3A4CYP2C19
SCHEMBL6899041 0.85 CYP3A4 (0.52) ALDH1A1LMNAMAPTNPSR1CYP3A4
SCHEMBL6897563 0.85 KMT2A (0.52) ALDH1A1LMNAMAPTCYP3A4CYP2C19
SCHEMBL6966587 0.84 RBP4 (0.52) ALDH1A1LMNAMAPTNPSR1KDM4E
SCHEMBL6782920 0.84 KMT2A (0.53) ALDH1A1LMNAMAPTCYP3A4CYP2C19
SCHEMBL6894906 0.83 P2RX7 (0.36) ALDH1A1LMNAMAPTNPSR1CYP3A4
SCHEMBL6896729 0.81 KMT2A (0.52) ALDH1A1LMNAMAPTNPSR1KDM4E
SCHEMBL6897989 0.81 KMT2A (0.41) ALDH1A1LMNAMAPTCYP3A4CYP2C19
SCHEMBL6897464 0.78 CYP3A4 (0.42) ALDH1A1LMNAMAPTNPSR1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6683184-B2 ANTITUMOR AGENTS SAMJIN PHARMACEUTICAL CO., LTD. (KR) 2004-01-27 US disclosed